Paolo Arosio

Prof. Paolo Arosio

Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy
orcid

Research Focus & Metrics

Academic Career Length

54Years (1973-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 1996 in Biochimica et Biophysica Acta (BBA) - Bioenergetics
Verified
Journal Article
Closed access
PHPauline M. Harrison
Pauline M. Harrison
Paolo ArosioPaolo Arosio
Paolo Arosio

1 July 2009 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
Paolo ArosioPaolo Arosio
Paolo Arosio
RIRosaria Ingrassia
Rosaria Ingrassia
PCpatrizia Cavadini
patrizia Cavadini

1 February 1991 in Nature
Verified
Journal Article
Closed access
DLDavid M. Lawson
David M. Lawson
PAPeter J. Artymiuk
Peter J. Artymiuk
SYStephen J. Yewdall
Stephen J. Yewdall
JSJohn M. A. Smith
John M. A. Smith
JLJ. Craig Livingstone
J. Craig Livingstone
PHPauline M. Harrison
Pauline M. Harrison


21 June 2004 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
LZLuigi Zecca
Luigi Zecca
ASAntonella Stroppolo
Antonella Stroppolo
AGAlberto Gatti
Alberto Gatti
DTDavide Tampellini
Davide Tampellini
MTMarco Toscani
Marco Toscani
FZFabio A. Zucca
Fabio A. Zucca
In this study, a comparative analysis of metal-related neuronal vulnerability was performed in two brainstem nuclei, the locus coeruleus (LC) and substantia nigra (SN), known targets of the etiological noxae in Parkinson's disease and related disorders. LC and SN pars compacta neurons both degenerate in Parkinson's disease and other Parkinsonisms; however, LC neurons are comparatively less affected and with a variable degree of involvement. In this study, iron, copper, and their major molecular forms like ferritins, ceruloplasmin, neuromelanin (NM), manganese-superoxide dismutase (SOD), and copper/zinc-SOD were measured in LC and SN of normal subjects at different ages. Iron content in LC was much lower than that in SN, and the ratio heavy-chain ferritin/iron in LC was higher than in the SN. The NM concentration was similar in LC and SN, but the iron content in NM of LC was much lower than SN. In both regions, heavy- and light-chain ferritins were present only in glia and were not detectable in neurons. These data suggest that in LC neurons, the iron mobilization and toxicity is lower than that in SN and is efficiently buffered by NM. The bigger damage occurring in SN could be related to the higher content of iron. Ferritins accomplish the same function of buffering iron in glial cells. Ceruloplasmin levels were similar in LC and SN, but copper was higher in LC. However, the copper content in NM of LC was higher than that of SN, indicating a higher copper mobilization in LC neurons. Manganese-SOD and copper/zinc-SOD had similar age trend in LC and SN. These results may explain at least one of the reasons underlying lower vulnerability of LC compared to SN in Parkinsonian syndromes.

27 March 2017 in IUBMB Life
Verified
Journal Article
Closed access
Paolo ArosioPaolo Arosio
Paolo Arosio
LELeonardo Elia
Leonardo Elia
MPMaura Poli
Maura Poli